Latest News
Stephen Saad, CEO of Aspen Holdings, comments on Sigma purchase
Australian News, New Zealand News, Announcements
An interview of Stephen Saad, CEO of Aspen Holdings.
Aspen Announcement to JSE
Australian News, Announcements
Announcement regarding the acquisition of the pharmaceutical business of Sigma Pharmaceuticals Limited by Aspen.
Aspen make a bid for Sigma
Australian News, Media Release
Aspen shareholders are advised that Aspen has submitted an indicative non-binding proposal to acquire, either directly or through a wholly-owned subsidiary, Sigma Pharmaceuticals Limited.
Aspen and GSK Agree On Series Of Strategic Transactions
Australian News, Announcements
Aspen, Africa's largest pharmaceutical manufacturer, has announced that it has agreed to multiple, strategic, inter-dependent transactions with a leading multinational pharmaceutical group, GlaxoSmithKline.
Diversity and Flexibility eNews
Australian News, New Zealand News, Media Release
Aspen's high level of flexibility has shown demonstrable business outcomes in addition to the attraction/retention of diverse talent, including consistently meeting sales objectives and extremely high value customer relationships.
Aspen take on Tritace and Cardizem
Australian News, Media Release
Aspen Pharmacare have signed a licensing agreement with Sanofi-Aventis for the distribution, sales and marketing of Tritace and Cardizem.
Aspen form alliance with Actavis
Aspen Australia have signed a license agreement with Actavis, taking on the sales, marketing and distribution of two products, Neotigason and Rapilysin.
